Abstract Background People with Parkinson's disease (PD) can develop multidomain
cognitive impairments; however, it is unclear whether different pathologies underlie domain …

ABSTRACT Background White matter hyperintensities (WMHs) have a role in cognitive
impairment in normal brain aging, while the effect on Parkinson's disease (PD) progression …

Background Growing evidence suggests an association between imaging biomarkers of
small vessel disease and future cognitive decline in Parkinson's disease (PD). Recently …

ABSTRACT Background Patients with Parkinson's disease (PD) present with a broad
spectrum of nonmotor features including autonomic disorders. More severe autonomic …

The purpose of this research was to examine the extent of global brain atrophy and white
matter hyperintensities (WMH) in early Parkinson's disease (PD) compared to normal …

ABSTRACT OBJECTIVES The clinical implications of white matter hyperintensities (WMH) in
non‐demented Parkinson's disease (PD) have not been thoroughly examined. To address …

Background White matter hyperintensities, prevalent in patients with Parkinson's disease
(PD), significantly affect parkinsonian motor symptoms. The objective of this study was to …

Background The aim of this work was to investigate the cortical and white matter changes
that underlie cognitive impairment in patients with incident Parkinson's disease (PD) disease …

Background Cortical neural correlates of ongoing cognitive decline in Parkinson's disease
(PD) have been suggested; however, the role of subcortical structures in longitudinal …

Objective The objective of this study was to determine the frequency and impact of
subjective cognitive complaint (SCC) in Parkinson's disease (PD) patients with normal …